Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carrieri

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Acta Neurologica|June 1, 1981
Circulating platelet aggregates in cerebrovascular diseases. Preliminary dataP Carrieri, S La Pia, A Indaco, et al.
Acta Neurologica|September 1, 1976
[Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes]A Mandarini, G A Buscaino, V Rossi, et al.
Pharmatherapeutica|January 1, 1983
Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approachP Carrieri, G Orefice, S La Pia, et al.
Revue D'Epidemiologie Et De Sante Publique|August 5, 1998
[Trends in HIV prenatal screening from 1992 to 1994 in South Eastern France]C Pradier, A Messiah, P Carrieri, et al.
Acta Neurologica|August 1, 1981
Cardiovascular risk factors and coronary damage in patients with ischemic brain diseaseL A Ferrara, P Strazzullo, D Mansi, et al.
Infection|July 3, 2003
Hepatitis C virus infection and cancer risk among HIV-infected individualsC Pradier, M P Carrieri, M Piche, et al.
HIV Medicine|June 21, 2017
Importance of the patient-physician interaction in assessing acceptability of HIV cure trialsC Protière, M Préau, P Carrieri, et al.
Cephalalgia : an International Journal of Headache|March 1, 1988
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover studyF Sorge, R De Simone, E Marano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Risks factors and prevention of Q fever endocarditisF Fenollar, P E Fournier, M P Carrieri, et al.
BMJ Open|October 22, 2014
HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventionsP Roux, L Sagaon-Teyssier, C Lions, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Acta Neurologica|June 1, 1981
Circulating platelet aggregates in cerebrovascular diseases. Preliminary dataP Carrieri, S La Pia, A Indaco, et al.
Acta Neurologica|September 1, 1976
[Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes]A Mandarini, G A Buscaino, V Rossi, et al.
Pharmatherapeutica|January 1, 1983
Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approachP Carrieri, G Orefice, S La Pia, et al.
Revue D'Epidemiologie Et De Sante Publique|August 5, 1998
[Trends in HIV prenatal screening from 1992 to 1994 in South Eastern France]C Pradier, A Messiah, P Carrieri, et al.
Acta Neurologica|August 1, 1981
Cardiovascular risk factors and coronary damage in patients with ischemic brain diseaseL A Ferrara, P Strazzullo, D Mansi, et al.
Infection|July 3, 2003
Hepatitis C virus infection and cancer risk among HIV-infected individualsC Pradier, M P Carrieri, M Piche, et al.
HIV Medicine|June 21, 2017
Importance of the patient-physician interaction in assessing acceptability of HIV cure trialsC Protière, M Préau, P Carrieri, et al.
Cephalalgia : an International Journal of Headache|March 1, 1988
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover studyF Sorge, R De Simone, E Marano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Risks factors and prevention of Q fever endocarditisF Fenollar, P E Fournier, M P Carrieri, et al.
BMJ Open|October 22, 2014
HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventionsP Roux, L Sagaon-Teyssier, C Lions, et al.
Pageof 13